Canaccord Genuity Initiates Actinium Pharmaceuticals At Buy

By: via Benzinga
Analysts at Canaccord Genuity initiated coverage on shares of Actinium Pharmaceuticals (NYSE: ATNM) with a Buy rating. The target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.